#JPM22: 4 top R&D chiefs discuss the key forces reshaping biopharma
On Tuesday I had a chance to sit down with 4 top R&D chiefs of some of the biggest organizations in the industry. There’s no question that the pandemic has been reshaping R&D, and I wanted to talk about the internal and external forces they’re experiencing that are continuing to remake our ideas about research and development. — John Carroll
Okay, everybody. This is John Carroll. I’m back. I’m the editor of Endpoints News back with you with our latest panel discussion related to R&D. I’ve got a great panel here today, and I really put a lot of thought into who I wanted to have on this panel, and I think in a lot of different respects it’s just gold all the way through.
Premium subscription required
Unlock this article along with other benefits by subscribing to one of our paid plans.